This bill inserts a single new subsection into The Provincial Health Authority Act that prevents operators of facilities designated for cancer care from charging parking fees to patients who attend to receive cancer treatments. The prohibition applies to the entity or person operating the facility.
The change removes a common out-of-pocket expense for people undergoing cancer treatment, but it also creates immediate operational questions for facilities and for third-party parking operators that rely on fee revenue. Facilities will need to alter access controls and accounting, and health authorities will have to decide how to replace lost revenue or absorb costs.
At a Glance
What It Does
The bill adds subsection 2-10(2) to the Act, establishing a statutory ban on charging parking fees to patients who attend designated cancer-care facilities to receive cancer treatments. The ban binds the 'health services entity or person operating a facility.'
Who It Affects
Cancer patients and their families, health authority facilities (including regional cancer centres), contracted parking operators and municipalities that collect parking revenue at health sites, and administrative staff responsible for parking controls and billing.
Why It Matters
It reduces a recurring financial burden for patients while forcing health authorities and operators to choose how to cover parking-related costs. The measure could set a provincial precedent for fee-free access at other specialized health services.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill’s operative change is compact but consequential. Rather than create a new program or funding stream, it simply makes it unlawful for a facility operator to charge a patient for parking when that patient is attending specifically to receive cancer treatment at a facility designated under the Act’s designation process (section 2-9).
That means the entitlement depends on two factual predicates: (1) the site must be formally designated for cancer care, and (2) the person must be attending for a cancer treatment.
Because the text ties the ban to designated facilities, mixed-use hospitals or campuses that host cancer services alongside other services will face practical sorting problems. Operators will need a way to distinguish eligible visits from ineligible ones (for example, a patient visiting for a non-cancer appointment, a family member or a visitor).
The statute does not include rules for verification, so facilities must adopt operational policies—badging, appointment-based validation, countersigning, or digital validation—to implement the prohibition without creating new access barriers.The bill also assumes an existing financial model for site parking. Many sites outsource parking management to private operators or rely on parking revenue to fund site security, maintenance, and capital projects.
With no dedicated provincial appropriation attached, health authorities and operators will either absorb the revenue loss, reallocate budgets, renegotiate contracts, or seek compensation from other funding streams. The text does not limit the ban by time of day or type of cancer treatment, nor does it mention companions, visitors, or patients attending for non-treatment cancer services (for example, diagnostic visits), leaving room for interpretation.Finally, the Act is silent on enforcement, compliance oversight, and remedies.
It does not create an administrative penalty scheme or specify which body monitors compliance. That absence means the practical enforceability of the ban will rest on internal policies, contract changes with private operators, and potential litigation or complaints rather than an explicit regulatory enforcement pathway.
The provision comes into force on Assent, so implementation planning will fall to facility operators and the provincial authority immediately after the bill becomes law.
The Five Things You Need to Know
The ban applies only to facilities that have been designated for the care of cancer patients pursuant to section 2-9 of The Provincial Health Authority Act.
The prohibition binds any 'health services entity or person operating a facility,' capturing both public operators and private or third-party parking contractors.
The statutory protection covers patients 'attending the facility to access cancer treatments'—the bill does not explicitly extend the waiver to companions, visitors, or patients attending for non-treatment visits.
The Act contains no penalty, inspectorate role, or administrative enforcement mechanism; it simply creates a statutory prohibition without an attached compliance regime.
The provision takes effect on Assent, meaning operators will need to implement operational changes and contract amendments quickly after the law comes into force.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This section supplies the act's short title: The Provincial Health Authority (Banning Parking Fees for Cancer Patients) Amendment Act. That is formal and has no operational effect, but it signals the law’s narrow, targeted purpose to regulators and managers who will implement the change.
Amendment to The Provincial Health Authority Act
Section 2 states that the Provincial Health Authority Act is amended as described. Procedurally, this ties the new prohibition into the existing statutory framework that governs facility designation, governance, and the powers of health services entities.
Ban on charging parking fees at designated cancer-care facilities
This is the core operative clause. It adds subsection 2-10(2): a health services entity or person operating a facility designated under section 2-9 must not charge parking fees to patients attending to access cancer treatments. Practically, the clause creates an absolute statutory bar (rather than a discretionary policy) but defines entitlement by reference to the designation regime and the purpose of the patient’s visit, which leaves operational questions—eligibility verification, scope of 'treatment,' and treatment for escorts—unanswered.
Coming into force
The Act comes into force on Assent. There is no delayed commencement or staged implementation period, so facilities and their operators will have to move quickly to create validation and billing processes and to negotiate any contract or budget changes necessary to comply.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Cancer patients undergoing treatment — they receive immediate relief from parking charges tied directly to the cost of attending repeated appointments, reducing one recurring out-of-pocket expense.
- Family members and caregivers who transport patients to treatment — where patients receive the waiver, accompanying caregivers may see lower overall trip costs if facilities adopt visitor validation practices.
- Patient advocacy organizations — the statutory change offers a clear legal basis to press for broader access measures and to monitor implementation across sites.
- Low-income and rural patients — those with longer travel distances or frequent treatment schedules stand to benefit disproportionately because parking costs compound over multiple visits.
Who Bears the Cost
- Health authority facilities and boards — they will lose parking revenue streams that may have funded security, maintenance, or site capital, requiring budget reallocations or new funding requests.
- Private parking operators contracted by facilities — contracts will need renegotiation; operators may face lost revenue and seek contract relief or compensation.
- Administrative and front-line staff — staff will absorb additional operational tasks (verifying eligibility, issuing validations, handling disputes) without the bill providing extra resources.
- Municipalities or other bodies that collect parking revenue at health sites — where fees flow to third parties, partnerships and revenue-sharing arrangements will be disrupted.
Key Issues
The Core Tension
The central dilemma is balancing immediate patient relief against operational and fiscal realities: the law removes a recurring out-of-pocket barrier for cancer patients but transfers those costs and administrative burdens to facility operators and funding streams without creating a funding or enforcement mechanism to manage that transfer.
The bill solves a straightforward equity problem—parking fees for people receiving cancer care—but it leaves multiple implementation choices unresolved. It ties the ban to statutory 'designations' under section 2-9, which narrows coverage to sites explicitly recognized for cancer care; the text does not address hybrid sites or satellite clinics that offer oncology services but are not formally designated.
That gap creates administrative work and potential disputes about which sites and visits qualify.
A second notable omission is enforcement. The Act creates no fine, inspection power, complaint mechanism, or direction to a provincial regulator.
In practice, compliance will rely on internal policy changes, contract amendments with private parking operators, and possible citizen complaints or litigation. Without a predictable enforcement pathway, some operators may delay or vary implementation.
Finally, there is a fiscal trade-off: the prohibition reduces patient costs but shifts the burden onto facility budgets, private contractors, or other payors. The bill does not provide transitional funding, so health authorities must decide whether to reallocate existing funds, reduce related services, or seek additional appropriations.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.